{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:15:14Z","timestamp":1791130514729,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,9,9]],"date-time":"2005-09-09T00:00:00Z","timestamp":1126224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00259-005-1919-4","type":"journal-article","created":{"date-parts":[[2005,9,8]],"date-time":"2005-09-08T15:12:48Z","timestamp":1126192368000},"page":"13-21","source":"Crossref","is-referenced-by-count":98,"title":["Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Dirk","family":"Hellwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Graeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne P.","family":"Hellwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Nestle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard W.","family":"Sybrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Martin","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,9]]},"reference":[{"key":"1919_CR1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00005382-199707000-00006","volume":"12","author":"RT Heelan","year":"1997","unstructured":"Heelan RT, Panicek DM, Burt ME, Caravelli JF, Martini N, Bains M, et al. Magnetic resonance imaging of the postpneumonectomy chest: normal and abnormal findings. J Thorac Imaging 1997;12:200\u20138","journal-title":"J Thorac Imaging"},{"key":"1919_CR2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archsurg.137.8.935","volume":"137","author":"JP Lamont","year":"2002","unstructured":"Lamont JP, Kakuda JT, Smith D, Wagman LD, Grannis FW Jr. Systematic postoperative radiologic follow-up in patients with non-small cell lung cancer for detecting second primary lung cancer in stage IA. Arch Surg 2002;137:935\u20138; discussion 938\u201340","journal-title":"Arch Surg"},{"key":"1919_CR3","first-page":"119","volume":"48","author":"RP Baum","year":"2004","unstructured":"Baum RP, Hellwig D, Mezzetti M. Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer. Q J Nucl Med 2004;48:119\u201342","journal-title":"Q J Nucl Med"},{"key":"1919_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiology.191.2.8153309","volume":"191","author":"EF Patz Jr","year":"1994","unstructured":"Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994;191:379\u201382","journal-title":"Radiology"},{"key":"1919_CR5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-5223(05)80018-2","volume":"110","author":"FG Duhaylongsod","year":"1995","unstructured":"Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE, Wolfe WG. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995;110:130\u20139; discussion 139\u201340","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1919_CR6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0360-3016(94)00622-R","volume":"32","author":"A Frank","year":"1995","unstructured":"Frank A, Lefkowitz D, Jaeger S, Gobar L, Sunderland J, Gupta N, et al. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings. Int J Radiat Oncol Biol Phys 1995;32:1495\u2013512","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1919_CR7","first-page":"788","volume":"36","author":"T Inoue","year":"1995","unstructured":"Inoue T, Kim EE, Komaki R, Wong FC, Bassa P, Wong WH, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995;36:788\u201393","journal-title":"J Nucl Med"},{"key":"1919_CR8","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1183\/09031936.99.14613769","volume":"14","author":"T Bury","year":"1999","unstructured":"Bury T, Corhay JL, Duysinx B, Daenen F, Ghaye B, Barthelemy N, et al. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999;14:1376\u201380","journal-title":"Eur Respir J"},{"key":"1919_CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2000-9063","volume":"54","author":"D Ukena","year":"2000","unstructured":"Ukena D, Hellwig D, Palm I, Rentz K, Leutz M, Hellwig AP, et al. Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in diagnosis of recurrent bronchial carcinoma. Pneumologie 2000;54:49\u201353","journal-title":"Pneumologie"},{"key":"1919_CR10","first-page":"1605","volume":"42","author":"RJ Hicks","year":"2001","unstructured":"Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, et al. The utility of 18F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. J Nucl Med 2001;42:1605\u201313","journal-title":"J Nucl Med"},{"key":"1919_CR11","first-page":"1640","volume":"45","author":"Z Keidar","year":"2004","unstructured":"Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, et al. PET\/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med 2004;45:1640\u20136","journal-title":"J Nucl Med"},{"key":"1919_CR12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jtcvs.2004.07.031","volume":"128","author":"D Hellwig","year":"2004","unstructured":"Hellwig D, Graeter TP, Ukena D, Georg T, Kirsch CM, Sch\u00e4fers HJ. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma. J Thorac Cardiovasc Surg 2004;128:892\u20139","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1919_CR13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00006231-200209000-00010","volume":"23","author":"HJ Jeong","year":"2002","unstructured":"Jeong HJ, Min JJ, Park JM, Chung JK, Kim BT, Jeong JM, et al. Determination of the prognostic value of [18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun 2002;23:865\u201370","journal-title":"Nucl Med Commun"},{"key":"1919_CR14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y","volume":"83","author":"V Ahuja","year":"1998","unstructured":"Ahuja V, Coleman RE, Herndon J, Patz EF Jr. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83:918\u201324","journal-title":"Cancer"},{"key":"1919_CR15","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1200\/JCO.2004.11.109","volume":"22","author":"RJ Downey","year":"2004","unstructured":"Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004;22:3255\u201360","journal-title":"J Clin Oncol"},{"key":"1919_CR16","first-page":"39","volume":"43","author":"K Higashi","year":"2002","unstructured":"Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 2002;43:39\u201345","journal-title":"J Nucl Med"},{"key":"1919_CR17","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.2003.12.004","volume":"21","author":"WA Weber","year":"2003","unstructured":"Weber WA, Petersen V, Schmidt B, Tyndale-Hines L, Link T, Peschel C, et al. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 2003;21:2651\u20137","journal-title":"J Clin Oncol"},{"key":"1919_CR18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2214\/ajr.174.3.1740769","volume":"174","author":"EF Patz Jr","year":"2000","unstructured":"Patz EF Jr, Connolly J, Herndon J. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. Am J Roentgenol 2000;174:769\u201374","journal-title":"Am J Roentgenol"},{"key":"1919_CR19","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2003.07.054","volume":"21","author":"MP Mac Manus","year":"2003","unstructured":"Mac Manus MP, Hicks RJ, Matthews JP, McKenzie A, Rischin D, Salminen EK, et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2003;21:1285\u201392","journal-title":"J Clin Oncol"},{"key":"1919_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1183\/09031936.02.00231802","volume":"19","author":"U Egermann","year":"2002","unstructured":"Egermann U, Jaeggi K, Habicht JM, Perruchoud AP, Dalquen P, Soler M. Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur Respir J 2002;19:464\u20138","journal-title":"Eur Respir J"},{"key":"1919_CR21","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1378\/chest.118.6.1621","volume":"118","author":"JW Asaph","year":"2000","unstructured":"Asaph JW, Keppel JF, Handy JR Jr, Douville EC, Tsen AC, Ott GY. Surgery for second lung cancers. Chest 2000;118:1621\u20135","journal-title":"Chest"},{"key":"1919_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/14017439209099057","volume":"26","author":"Y Watanabe","year":"1992","unstructured":"Watanabe Y, Shimizu J, Oda M, Tatsuzawa Y, Hayashi Y, Iwa T. Second surgical intervention for recurrent and second primary bronchogenic carcinomas. Scand J Thorac Cardiovasc Surg 1992;26:73\u20138","journal-title":"Scand J Thorac Cardiovasc Surg"},{"key":"1919_CR23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0360-3016(92)91016-G","volume":"24","author":"WJ Curran Jr","year":"1992","unstructured":"Curran WJ Jr, Herbert SH, Stafford PM, Sandler HM, Rosenthal SA, McKenna WG, et al. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy? Int J Radiat Oncol Biol Phys 1992;24:25\u201330","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1919_CR24","volume-title":"WHO, international histological classification of tumours","author":"WD Travis","year":"1999","unstructured":"Travis WD, Sobin LH. Histological typing of lung and pleural tumours. 3rd ed. WHO, International histological classification of tumours. Berlin Heidelberg New York: Springer; 1999","edition":"3"},{"key":"1919_CR25","volume-title":"WHO, international histological classification of tumours","author":"World Health Organization","year":"1981","unstructured":"World Health Organization. Histological typing of lung tumours. 2nd ed. WHO, international histological classification of tumours. Geneva: World Health Organization; 1981","edition":"2"},{"key":"1919_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2000-6949","volume":"54","author":"M Thomas","year":"2000","unstructured":"Thomas M, Gatzemeier U, Goerg R, Matthiessen W, Morr H, Schonfeld N, et al. Recommendations on the diagnosis of bronchial carcinoma. German Pneumology Society. Pneumologie 2000;54:361\u201371","journal-title":"Pneumologie"},{"key":"1919_CR27","first-page":"1771","volume":"35","author":"VJ Lowe","year":"1994","unstructured":"Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994;35:1771\u20136","journal-title":"J Nucl Med"},{"key":"1919_CR28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(04)01564-5","volume":"5","author":"J Vansteenkiste","year":"2004","unstructured":"Vansteenkiste J, Fischer BM, Dooms C, Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol 2004;5:531\u201340","journal-title":"Lancet Oncol"},{"key":"1919_CR29","first-page":"1308","volume":"35","author":"LM Hamberg","year":"1994","unstructured":"Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994;35:1308\u201312","journal-title":"J Nucl Med"},{"key":"1919_CR30","first-page":"871","volume":"43","author":"A Matthies","year":"2002","unstructured":"Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002;43:871\u20135","journal-title":"J Nucl Med"},{"key":"1919_CR31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2001-16201","volume":"55","author":"D Hellwig","year":"2001","unstructured":"Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM. Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren. Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000. Pneumologie 2001;55:367\u201377","journal-title":"Pneumologie"},{"key":"1919_CR32","first-page":"1016","volume":"39","author":"K Higashi","year":"1998","unstructured":"Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998;39:1016\u201320","journal-title":"J Nucl Med"},{"key":"1919_CR33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2001-16200","volume":"55","author":"D Hellwig","year":"2001","unstructured":"Hellwig D, Gr\u00f6schel A, Rentz K, Sybrecht GW, Kirsch CM, Ukena D. Aussagekraft der Positronen-Emissions-Tomographie mit F-18-Fluordesoxyglukose (FDG-PET) beim Bronchioloalveolarzellkarzinom (BAC). Pneumologie 2001;55:363\u20136","journal-title":"Pneumologie"},{"key":"1919_CR34","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s00259-002-0853-y","volume":"29","author":"CS Yap","year":"2002","unstructured":"Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging 2002;29:1166\u201373","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1919_CR35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.285.7.914","volume":"285","author":"MK Gould","year":"2001","unstructured":"Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285:914\u201324","journal-title":"JAMA"},{"key":"1919_CR36","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1164\/ajrccm.149.6.7516252","volume":"149","author":"HA Jones","year":"1994","unstructured":"Jones HA, Clark RJ, Rhodes CG, Schofield JB, Krausz T, Haslett C. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med 1994;149:1635\u20139","journal-title":"Am J Respir Crit Care Med"},{"key":"1919_CR37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000061294","volume":"37","author":"U Nestle","year":"2002","unstructured":"Nestle U, Hellwig D, Fleckenstein J, Walter K, Ukena D, R\u00fcbe C, et al. Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients. Front Radiat Ther Oncol 2002;37:26\u201333","journal-title":"Front Radiat Ther Oncol"},{"key":"1919_CR38","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1200\/JCO.1999.17.10.3201","volume":"17","author":"JF Vansteenkiste","year":"1999","unstructured":"Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, et al. Prognostic importance of the standardized uptake value on 18F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999;17:3201\u20136","journal-title":"J Clin Oncol"},{"key":"1919_CR39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00006231-200008000-00002","volume":"21","author":"K Higashi","year":"2000","unstructured":"Higashi K, Ueda Y, Ayabe K, Sakurai A, Seki H, Nambu Y, et al. FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features. Nucl Med Commun 2000;21:707\u201314","journal-title":"Nucl Med Commun"},{"key":"1919_CR40","first-page":"635","volume":"43","author":"L Geworski","year":"2002","unstructured":"Geworski L, Knoop BO, de Wit M, Ivancevic V, Bares R, Munz DL. Multicenter comparison of calibration and cross calibration of PET scanners. J Nucl Med 2002;43:635\u20139","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-1919-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-005-1919-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-1919-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:58:52Z","timestamp":1558713532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-005-1919-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,9]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["1919"],"URL":"https:\/\/doi.org\/10.1007\/s00259-005-1919-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,9]]}}}